Loading briefing details...
News Abstract
By: PointLine Media Research & Editorial Team
Topic:Business,Health,Science & Environment
November 17, 2026
Researchers have identified a specific protein, MOCCI, that enables lung cancer cells to spread to lymph nodes by altering their metabolic function. This protein drives oxidative phosphorylation, a process that boosts energy production and facilitates the migration of cancer cells.
By analyzing single-cell data and spatial transcriptomics, the team discovered that MOCCI-active cells secrete a signaling molecule called GDF15. This molecule interacts with nearby immune cells, specifically T follicular helper cells, inducing a state of dysfunction that prevents the immune system from mounting an effective response.
The study demonstrates that high levels of MOCCI are linked to more aggressive nodal status and poorer patient survival outcomes. Inhibiting this metabolic pathway may offer a new strategy for stopping cancer from disseminating through the lymphatic system.
Metabolic reprogramming is increasingly recognized as a fundamental hallmark of cancer progression. As researchers move beyond simple genetic sequencing, they are now mapping how specific metabolic states create localized immunosuppressive environments that allow tumors to evade detection and spread.
This study highlights the growing importance of spatial multi-omics in oncology, which allows scientists to see exactly how tumor cells "talk" to their neighbors. Understanding these micro-interactions is becoming a top priority in developing targeted therapies that go beyond traditional chemotherapy to address the root causes of metastasis.